• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在人类心肺复苏期间,血管加压素或血管加压素加硝酸甘油与肾上腺素联合应用对动脉血压的影响。

Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans.

作者信息

Ducros Laurent, Vicaut Eric, Soleil Christian, Le Guen Morgan, Gueye Papa, Poussant Thomas, Mebazaa Alexandre, Payen Didier, Plaisance Patrick

机构信息

Department of Anesthesiology and Critical Care, Lariboisière University Hospital, Paris, France.

出版信息

J Emerg Med. 2011 Nov;41(5):453-9. doi: 10.1016/j.jemermed.2010.02.030. Epub 2010 Apr 24.

DOI:10.1016/j.jemermed.2010.02.030
PMID:20456906
Abstract

BACKGROUND

Infusion of a vasopressor during cardiopulmonary resuscitation (CPR) in humans increases end decompression (diastolic) arterial blood pressure, and consequently increases vital organ perfusion pressure and survival. Several vasoactive drugs have been tested alone or in combination, but their hemodynamic effects have not been investigated clinically in humans.

STUDY OBJECTIVE

We tested the hypothesis that epinephrine (1 mg) co-administered with vasopressin (40 IU) ± nitroglycerin (300 μg) results in higher diastolic blood pressure than epinephrine alone.

STUDY DESIGN

A prospective, randomized, double-blinded controlled trial in the prehospital setting. The study included 48 patients with witnessed cardiac arrest. Patients received either epinephrine alone (E alone) or epinephrine plus vasopressin (E+V) or epinephrine plus vasopressin plus nitroglycerin (E+V+N). A femoral arterial catheter was inserted for arterial pressure measurement.

OUTCOME MEASURES

The primary end point was diastolic blood pressure during CPR, 15 min after the first drug administration (T = 15 min).

RESULTS

After exclusions, a total of 44 patients were enrolled. Diastolic blood pressures (mm Hg) at T = 15 min were not statistically different between groups (median [interquartile range]: 20 [10], 15 [6], and 15 [13] for E alone, E+V, and E+V+N, respectively. The rate of return of spontaneous circulation was 63% (n = 10) in the epinephrine group, 43% (n = 6) in the epinephrine plus vasopressin group, and 36% (n = 5) in the triple therapy group (NS).

CONCLUSIONS

Addition of vasopressin or vasopressin plus nitroglycerin to epinephrine did not increase perfusion blood pressure compared to epinephrine alone in humans in cardiac arrest, suggesting the absence of benefit in using these drug combination(s).

摘要

背景

在对人类进行心肺复苏(CPR)期间输注血管加压药可提高舒张期(减压期)动脉血压,从而增加重要器官灌注压并提高生存率。已经单独或联合测试了几种血管活性药物,但尚未在人体中对其血流动力学效应进行临床研究。

研究目的

我们检验了以下假设,即肾上腺素(1毫克)与血管加压素(40国际单位)±硝酸甘油(300微克)联合使用比单独使用肾上腺素可导致更高的舒张压。

研究设计

一项在院前环境中进行的前瞻性、随机、双盲对照试验。该研究纳入了48例目击心脏骤停患者。患者接受单独使用肾上腺素(仅E组)或肾上腺素加血管加压素(E + V组)或肾上腺素加血管加压素加硝酸甘油(E + V + N组)治疗。插入股动脉导管以测量动脉压。

观察指标

主要终点是首次给药后15分钟(T = 15分钟)心肺复苏期间的舒张压。

结果

排除后,共纳入44例患者。T = 15分钟时,各组间舒张压(毫米汞柱)无统计学差异(中位数[四分位间距]:仅E组为20[10],E + V组为15[6],E + V + N组为15[13])。肾上腺素组自主循环恢复率为63%(n = 10),肾上腺素加血管加压素组为43%(n = 6),三联疗法组为36%(n = 5)(无统计学差异)。

结论

在心脏骤停的人体中,与单独使用肾上腺素相比,在肾上腺素中添加血管加压素或血管加压素加硝酸甘油并未增加灌注血压,这表明使用这些药物组合并无益处。

相似文献

1
Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans.在人类心肺复苏期间,血管加压素或血管加压素加硝酸甘油与肾上腺素联合应用对动脉血压的影响。
J Emerg Med. 2011 Nov;41(5):453-9. doi: 10.1016/j.jemermed.2010.02.030. Epub 2010 Apr 24.
2
Epinephrine, vasopressin, and nitroglycerin improve neurologic outcome in porcine asphyxial cardiac arrest.肾上腺素、血管加压素和硝酸甘油可改善猪窒息性心跳骤停的神经功能结局。
Am J Emerg Med. 2012 Oct;30(8):1549-54. doi: 10.1016/j.ajem.2012.01.008. Epub 2012 Mar 3.
3
Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation.血管加压素与肾上腺素联用及单用肾上腺素在心肺复苏中的比较
N Engl J Med. 2008 Jul 3;359(1):21-30. doi: 10.1056/NEJMoa0706873.
4
Effects of epinephrine and vasopressin on end-tidal carbon dioxide tension and mean arterial blood pressure in out-of-hospital cardiopulmonary resuscitation: an observational study.肾上腺素和血管加压素对院外心肺复苏中呼气末二氧化碳分压和平均动脉血压的影响:一项观察性研究。
Crit Care. 2007;11(2):R39. doi: 10.1186/cc5726.
5
Revised resuscitation guidelines: adrenaline versus adrenaline/vasopressin in a pig model of cardiopulmonary resuscitation--a randomised, controlled trial.修订后的复苏指南:心肺复苏猪模型中肾上腺素与肾上腺素/血管加压素的比较——一项随机对照试验。
Resuscitation. 2007 Nov;75(2):380-8. doi: 10.1016/j.resuscitation.2007.04.022. Epub 2007 Jun 20.
6
Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest.血管加压素、肾上腺素和皮质类固醇用于院内心脏骤停。
Arch Intern Med. 2009 Jan 12;169(1):15-24. doi: 10.1001/archinternmed.2008.509.
7
Combination drug therapy with vasopressin, adrenaline (epinephrine) and nitroglycerin improves vital organ blood flow in a porcine model of ventricular fibrillation.在猪心室颤动模型中,血管加压素、肾上腺素和硝酸甘油联合药物治疗可改善重要器官的血流。
Resuscitation. 2002 Aug;54(2):187-94. doi: 10.1016/s0300-9572(02)00096-5.
8
Vasopressors are essential during cardiopulmonary resuscitation in rats: Is vasopressin superior to adrenaline?血管升压药在大鼠心肺复苏过程中至关重要:血管加压素是否优于肾上腺素?
Resuscitation. 2007 Jan;72(1):137-44. doi: 10.1016/j.resuscitation.2006.05.015. Epub 2006 Oct 27.
9
Resuscitation strategies from bupivacaine-induced cardiac arrest.布比卡因诱发心脏骤停的复苏策略。
Paediatr Anaesth. 2012 Feb;22(2):124-9. doi: 10.1111/j.1460-9592.2011.03688.x. Epub 2011 Aug 29.
10
A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation.血管加压素与肾上腺素用于院外心肺复苏的比较。
N Engl J Med. 2004 Jan 8;350(2):105-13. doi: 10.1056/NEJMoa025431.

引用本文的文献

1
Comparison of different treatments of out-of-hospital cardiac arrest: A systematic review and network meta-analysis.院外心脏骤停不同治疗方法的比较:一项系统评价和网状Meta分析
Medicine (Baltimore). 2025 Mar 7;104(10):e41698. doi: 10.1097/MD.0000000000041698.
2
Mortality, morbidity & clinical outcome with different types of vasopressors in out of hospital cardiac arrest patients- a systematic review and meta-analysis.不同类型血管加压素在院外心脏骤停患者中的死亡率、发病率和临床结局:系统评价和荟萃分析。
BMC Cardiovasc Disord. 2024 May 30;24(1):283. doi: 10.1186/s12872-024-03962-4.
3
Effectiveness of Vasopressin Against Cardiac Arrest: A Systematic Review of Systematic Reviews.
血管加压素治疗心脏骤停的有效性:系统评价的系统综述
Cardiovasc Drugs Ther. 2024 Mar 12. doi: 10.1007/s10557-024-07571-3.
4
Therapeutic effects of vasopressin on cardiac arrest: a systematic review and meta-analysis.血管加压素对心脏骤停的治疗效果:系统评价和荟萃分析。
BMJ Open. 2023 Apr 17;13(4):e065061. doi: 10.1136/bmjopen-2022-065061.
5
Augmented-Medication CardioPulmonary Resuscitation (AMCPR) trial: a study protocol for a randomized controlled trial.强化药物心肺复苏(AMCPR)试验:一项随机对照试验的研究方案
Clin Exp Emerg Med. 2022 Dec;9(4):361-366. doi: 10.15441/ceem.22.367. Epub 2022 Nov 2.
6
Meta-Analysis of the Factors Influencing the Restoration of Spontaneous Circulation After Cardiopulmonary Resuscitation.心肺复苏后影响自主循环恢复因素的Meta分析
Front Physiol. 2022 Mar 8;13:834352. doi: 10.3389/fphys.2022.834352. eCollection 2022.
7
Adrenaline to improve survival in out-of-hospital cardiac arrest: the PARAMEDIC2 RCT.肾上腺素提高院外心脏骤停患者的生存率:PARAMEDIC2 RCT 研究。
Health Technol Assess. 2021 Apr;25(25):1-166. doi: 10.3310/hta25250.
8
Adrenaline and vasopressin for cardiac arrest.用于心脏骤停的肾上腺素和血管加压素。
Cochrane Database Syst Rev. 2019 Jan 17;1(1):CD003179. doi: 10.1002/14651858.CD003179.pub2.
9
Epinephrine in cardiac arrest: systematic review and meta-analysis.心脏骤停时的肾上腺素:系统评价与荟萃分析。
Rev Lat Am Enfermagem. 2016 Dec 8;24:e2821. doi: 10.1590/1518-8345.1317.2821.
10
Effect of the AutoPulse automated band chest compression device on hemodynamics in out-of-hospital cardiac arrest resuscitation.自动脉搏带胸部按压装置对院外心脏骤停复苏中血液动力学的影响。
Intensive Care Med. 2010 Jul;36(7):1256-60. doi: 10.1007/s00134-010-1784-x. Epub 2010 Mar 6.